Upcoming Medical Conferences in New YorkSearch Criteria : United States of America New York
Oct 24 - 25, 2019 | AMA PRA Category 1 10.75 | USD $399 | New York, New York
12th International Congress on Myeloproliferative Neoplasms (MPNs) is organized by Melton Medical Education, LLC and will be held from Oct 24 - 25, 2019 at The Westin New York at Times Square, New York City, New York, United States of America. Target Audience: The 12th International Congress on MPNs is specifically designed for hematologists, medical oncologists, and other healthcare professionals (physicians, clinicians, physicians-in-training, oncology nurses, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with myeloproliferative neoplasms and chronic myeloid leukemia. Accreditation: The Medical Society of the State of New York designates this live activity for a maximum of 10.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Description: Since the inaugural Congress in 2001, this meeting has become the premier forum for discussion on the latest advances in myeloproliferative neoplasms (MPNs). This year, Congress will focus on timely topics of interest to hematologists and oncologists who treat patients with these rare disorders. The Congress program format will utilize case presentations to highlight the essential features of MPN pathophysiology, diagnosis, and management, as well as the roles of next-generation sequencing and the MPN driver mutation and allele burden in clinical decision making. In addition to defining the role of pegylated interferon and its long-acting derivatives in MPN therapy, the role of immunotherapy in the MPNs and novel agents for MPN treatment will be reviewed New this year will be a discussion of the management of accelerated and blast phase MPN, patient selection for bone marrow transplantation, and how to integrate MPN patient symptom scores with therapeutic planning. Congress attendees will have the opportunity to participate in a variety of educational formats including didactic sessions, case reviews, poster sessions and oral abstract presentations, as well as multiple networking and one-on-one discussion opportunities. To allow more time for participant questions, time has also been allotted for a panel discussion with Congress faculty. Educational Objectives: After participating in this program, participants should be able to: • Describe underlying molecular and genetic events involved in MPNs and how these events could be utilized in the clinic. • Discuss the role and utilization of current approved therapies in MPNs, as well as the potential role of agents in development. • Assess how to manage symptoms and therapy-associated adverse events for patients with MPNs. • Outline the current treatment strategies (including treatment termination) for patients with chronic myeloid leukemia (CML). Additional details will be posted as soon as they are available.
Oct 26 - 27, 2019 | New York, New York
ASCP Fall Psychopharmacology Update: State-of-the-Art Meeting is organized by American Society of Clinical Psychopharmacology (ASCP) and will be held from Oct 26 - 27, 2019 at The Roosevelt Hotel, New York City, New York, United States of America. Additional details will be posted as soon as they are available.
Dec 06, 2019 | New York, New York
4th Annual Intraoperative Imaging Technologies for Cancer Detection and Treatment is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held on Dec 06, 2019 at Zuckerman Research Center, New York, United States of America. Overview The overall goal of the course is to upgrade the learner on current and next generation image-guided intraoperative technologies for improving cancer detection, treatment, and patient outcomes. It will include didactic lectures and hands-on workshops featuring the latest technological innovations. This course is directed towards surgical oncologists, radiologists, pathologists, engineers, research scientists and technologists. Objectives • Enhance understanding of the role of optical image-guided structural and functional visualization systems for individualizing treatment. • Highlight new surgical imaging analysis tools for understanding complex 3D anatomy. • Review advances in three-dimensional printing for surgical planning and patient-specific implant designs. • Develop familiarity with next-generation imaging probes and paradigms for guiding therapeutic interventions, biopsies, and surgical decision-making. • Facilitate integration of next-generation intraoperative tools into clinical trial designs and routine practice. Additional details will be posted as soon as they are available.
Dec 09 - 10, 2019 | CME 13.75 | USD $450 | New York, New York
16th International B.E.S.T. (Bariatric Endoscopic Surgical Trends) is organized by Cine-Med Inc. and will be held from Dec 09 - 10, 2019 at The Roosevelt Hotel, New york city, New York, United States of America. Who Should Attend: Physicians, nurses, trainees and allied health clinicians involved in the treatment of obesity with surgery. Accreditation Physicians: Ciné-Med designates this live activity for a maximum of 13.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses: This activity provides 13.75 contact hours for nurses. Activity Goal: This activity is designed to address the following core and team competencies: Patient Care, Medical Knowledge, Practice-based Learning, and Interprofessional Collaboration. Overview: This year's B.E.S.T. conference will focus on the quest for a personalized approach in bariatric and metabolic surgery. From indications to outcomes, we will be defining the role for primary, revisional procedures, and emerging technologies. The specialized division of bariatric surgery is increasingly challenging, both in the area of expertise and in managing outcomes and complications. Additionally, obesity as a chronic disease provides many areas of both advancement and discussion. Over the course of the two-day conference, the program will include more than 10 live-surgery transmissions from hospitals across the region as well as from international colleagues around the world. The procedures will be performed in full accordance with current guidelines for live surgery. In addition, lectures, debates with audience polling, a "Shark Tank" presentation of current innovations, and conclusive wrap-ups after each session will serve to orient conference participants towards possible algorithms for different revisional procedures. Objectives: By attending this activity, participants will be able to: • Define an algorithm for the management of GERD after sleeve gastrectomy and the preoperative evaluation for patients with potential risk for post-op GERD • Identify the appropriate applications of robotic, computer-assisted technology in bariatric surgery • Define and clarify the current state of knowledge regarding single anastomosis procedures • Review and determine the anatomy and physiology of the small bowel and its implications regarding bariatric surgery • Explain how to evaluate patients with recidivism, and identify select steps for revisional surgery indications and strategies • Identify strategies for the high-risk patient • Identify appropriate indicators for bariatric endoscopic interventions Additional details will be posted as soon as information is available.
Dec 13 - 14, 2019 | New York, New York
Mastering the Management of Aortic Valve Disease: A Case-Based Approach is organized by Cleveland Clinic Center for Continuing Education and will be held from Dec 13 - 14, 2019 at JW Marriott Essex House New York, New York, United States of America. Additional details will be posted as soon as they are available.
Dec 13 - 17, 2019 | New York, New York
73rd PostGraduate Assembly in Anesthesiology (PGA) is organized by New York State Society of Anesthesiologists, Inc. (NYSSA) and would be held during Dec 13 - 17, 2019 at New York, United States of America. Additional Details will be posted as soon as they are available.
4th Annual International Congress on Immunotherapies in Cancer: Focus on Practice-Changing Application
Dec 14, 2019 | New York, New York
4th Annual International Congress on Immunotherapies in Cancer: Focus on Practice-Changing Application is organized by Physicians' Education Resource, LLC (PER) and will be held on Dec 14, 2019 at InterContinental New York Times Square, New York, United States of America. Target Audience: This educational program is directed toward oncologists, nurses, and pharmacists. Participants will be primarily those whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on immunotherapies and their evolving roles in the treatment of patients with cancer. Overview: The recent development of immunotherapies to treat cancer has transformed the way that clinicians think about managing their patients with many forms of malignancies. The speed at which basic science and clinical trial information continue to emerge in this area, however, creates practice and/or educational gaps for busy clinicians who strive to maintain state-of-the art care for their patients with cancer. This field is one of the most clinically relevant and exciting areas of novel drug development in oncology. This exciting and fast-paced congress will provide a multi-module, curriculum-based program that focuses exclusively on immunotherapies and their application to the management of cancer. This intensive, 1-day interactive program will provide a comprehensive review of the key data sets that are most relevant to the application of these novel strategies for the clinician who manages some of the most difficult-to-treat forms of cancer. The program will focus on the practical application of recent clinical trial results that have shaped current and evolving clinical management, evolving biomarker information, the latest basic science findings, and the most highly anticipated clinical trials in the field. Topics of particular interest will be optimal timing of checkpoint inhibitors, identification of patients with cell surface expression of a target antigen who would be good candidates for CAR T-cell treatment, using combination immunotherapies in patients with driver mutations (eg, EGFR/ALK), and the use of combination therapies targeting the IDO pathway in patients with advanced melanoma. Learning Objectives: Upon successful completion of this educational activity, you should be better prepared to: • Explain current and evolving mechanistic approaches concerning how the immune system can be targeted in the treatment of cancer • Evaluate recent clinical trial findings on immuno-oncology strategies, and how they can be practically applied to the management of cancer in multiple lines of care • Discuss emerging methods to personalize care via the use of biomarkers and other methods to individualize the use of immuno-oncology strategies • Describe how common and uncommon adverse events, associated with the use of immuno-oncology strategies, can be proactively mitigated and managed • Detail important remaining clinical questions in the field, and highly anticipated ongoing clinical trials, that are evaluating emerging immuno-oncology strategies
Feb 08, 2020 | New York, New York
16th Annual International Symposium on Melanoma and Other Cutaneous Malignancies is organized by Physicians' Education Resource, LLC (PER) and will be held on Feb 08, 2020 at InterContinental New York Times Square, New York, United States of America. Target Audience This educational activity is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of melanoma and other cutaneous malignancies will be invited to participate. What you will learn: • The current use of checkpoint inhibitors and other immunotherapeutic strategies, including intralesional therapies, both as single-agent therapy and in combination with other regimens • Insights into emerging therapeutic targets, including agents targeting LAG3, STING, and other pathways • Best practices for use of BRAF/MEK inhibitors as single-agent therapy and in combination with other therapies • Management strategies in the setting of regional disease and metastatic disease • Strategies for the mitigation of potential adverse events with targeted treatments and checkpoint inhibitors Benefits of Attending: • Interact with top experts in the field of cutaneous malignancies • Gain actionable insights to improve the treatment of your patients • Recognize the role of targeted therapies, checkpoint inhibitors, and combination therapies across the cutaneous malignancies • Recognize current best practices for management of adverse events with targeted therapies and checkpoint inhibitors • Network with colleagues and peers Overview This is a single-day educational conference discussing emerging treatments in melanoma, basal cell carcinoma, squamous cell carcinoma, and Merkel cell carcinoma. This concise and engaging program will inform your practice with insights from world-renowned experts on evolving standards of care in melanoma and other cutaneous malignancies. Learning Objectives At the conclusion of this symposium, you should be better prepared to: • Recognize best practices form the latest clinical trials in cutaneous malignancies to manage the full range of cutaneous malignancies across stages of disease • Understand best practice for multidisciplinary identification and management of the adverse events associated with treatment across cutaneous malignancies • Outline best practices for use of biomarkers in personalizing care in patients with melanoma, basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, and other cutaneous malignancies • Contextualize current evidence in terms of evolving standards of care to support the optimal sequencing of therapies across melanoma, basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, and other cutaneous malignancies
Mar 01, 2020 | CME 7.50 | USD $1699 | New York, New York
Anti-Aging - Modules 1 & 2 is organized by Empire Medical Training (EMT), Inc and will be held on Mar 01, 2020 at The Westin New York at Times Square, New York City, New York, United States of America. Target Audience: This activity designed to meet the educational needs of physicians, physician assistants, nurses and other healthcare professionals interested in treatment of pain management. Accreditation: Physicians AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physician Assistants NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Nurses AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is awarded 7.5 Contact Hours. Description: This 9-hour, intensive course has been expanded to include both Modules 1 and 2. The Anti Aging program is a very detailed oriented, comprehensive program for Physicians and other Health Care Professionals who are interested in integrating this new specialty into their practice. The program is taught by our lead instructor and Physician Advisory Board Director, Ann Robins, MD, a Board Certified Specialist in Internal Medicine and Anti-Aging Medicine and a graduate from the prestigious Yale University School of Medicine. Dr. Robins is also residency trained from the Mayo Clinic in St Paul, MN. In addition to her advisory role with Empire Medial Training, Dr Robins maintains a very busy Internal Medicine Practice with a focus on Regenerative and Weight Management Medicine. Anti-aging medicine compliments conventional medicine, the specialty originated on using and applying advanced scientific methods for the early detection, prevention, treatment, and reversal of age-related dysfunction, chronic disorders, and other health related diseases. Anti-aging is a healthcare model based upon evidenced based interventional medical care that are consistent with those applied in other preventive health specialties. The anti-aging medical model will allow you to both extend lifespan as well as prolong the health span for patients allowing them a greater period of time that they may live productively and independently. Learning Objectives: • Competently administer personalized anti-aging services to their patient in order to optimize outcomes. • Describe the risks, pitfalls and potential health risks of patients undergoing anti-agng treatments. • Apply generally accepted protocols of integrative approaches to anti-aging services. • Evaluate laboratory and clinical testing, patient and family histories, and other associated findings to enhance patient outcomes while utilizing the best approach to treatment. • Monitor potential complications arising from anti-aging procedures and treat effectively to provide optimal patient outcomes. Additional details will be posted as soon as they are available.
Mar 07 - 08, 2020 | CE Hours 16.00 | USD $575 | New York, Connecticut
Comprehensive Treatment of the Foot & Ankle is organized by Great Lakes Seminars (GLS) and will be held from Mar 07 - 08, 2020 at New York, Connecticut, United States of America. Accreditation: This course has been submitted for 16 continuing education hours. Approval amounts may vary per state. Certificates of attendance with the number of course hours will be given to each participant at the completion of the course. Course Description: This course takes a significantly different approach to treatment of the foot and ankle. It focuses on how to restore normal foot mechanics and take stress off of the soft tissues in the foot through manual techniques, taping and orthotic therapy. It shows you common foot dysfunctions that lead to common foot diagnoses. The manual therapy techniques covered include joint mobilizations and myofascial release / soft tissue mobilizations. You will make a pair of temporary orthotics in the class, utilizing a structural and functional approach, which can be easily replicated on Monday morning. As with all of our manual therapy courses, this seminar will follow a progression of principles and reinforce them throughout the 16 hours. This course is at least 75% hands-on lab, and will give the clinician hands-on skills they use immediately upon their return to the clinical setting. Topics Covered: • Introduction to a comprehensive approach to manual treatment of the foot & ankle • Overview of anatomy of the foot & ankle complex and its effect on mobilizations, MFR, etc • Introduction and review of the concepts of functional joint mobilization, MFR, foot taping, balance re-education and orthotic therapy • Mobilization: distal tib-fib, talocrural, subtalar, cuboid, navicular, misc tarsals • MFR: foot, ankle and lower extremity release techniques, scar releases • Taping: for the arch, ankle, navicular sling, peroneus longus, hallux valgus, calcaneal, fat pad • Orthotic therapy with temporary orthotics • Balance re-education of the foot & ankle complex • Application to specific clinical situations Course Objectives: At the completion of this seminar, the participant will be able to: • Demonstrate the ability to select the correct mobilization technique, myofascial technique, and correct taping, balance re-education or orthotic technique based on a patient's clinical presentation. • Demonstrate the correct hand technique, the correct grading of joint mobilization, and describe the specific physiologic effects of joint mobilization. • Demonstrate the correct specific techniques for MFR of the foot and lower extremity to treat foot and ankle dysfunctions. • Demonstrate the correct specific techniques for taping of the foot and ankle. Additional details will be posted as soon as information is available.